Quick Answer
ORTHOPEDIATRICS CORP reported Total Assets of $508.63 million for the year ending 2025.
- ORTHOPEDIATRICS CORP showed an increase of +7.5% in Total Assets from 2024 to 2025.
- This data is from ORTHOPEDIATRICS CORP's annual report (Form 10-K), filed with the SEC on March 4, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2017: $41.08 million | Q1 2018: $80.64 million | Q2 2018: $77.85 million | Q3 2018: $76.88 million | Q1 2019: $112.01 million | Q2 2019: $151.43 million | Q3 2019: $153.42 million | Q1 2020: $174.20 million | Q2 2020: $328.49 million | Q3 2020: $308.00 million | Q1 2021: $313.35 million | Q2 2021: $307.66 million | Q3 2021: $303.59 million | Q1 2022: $301.00 million | Q2 2022: $330.94 million | Q3 2022: $430.05 million | Q1 2023: $426.29 million | Q2 2023: $434.87 million | Q3 2023: $432.44 million | Q1 2024: $437.19 million | Q2 2024: $430.76 million | Q3 2024: $489.29 million | Q1 2025: $470.25 million | Q2 2025: $503.61 million | Q3 2025: $493.49 million.
- Over the full 10 years of available data (2016 to 2025), ORTHOPEDIATRICS CORP's Total Assets has grown by 1,558.1%.
- Historical annual values: Fiscal year 2025: $508.63 million | Fiscal year 2024: $473.21 million | Fiscal year 2023: $438.75 million | Fiscal year 2022: $427.73 million | Fiscal year 2021: $304.27 million | Fiscal year 2020: $320.41 million | Fiscal year 2019: $182.15 million | Fiscal year 2018: $112.11 million | Fiscal year 2017: $82.30 million | Fiscal year 2016: $30.68 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: